Publications by authors named "Kaori Yoriki"

Partial cystectomy is often performed to treat bladder endometriosis. However, there are no reports of bladder rupture more than 10 years after cystectomy. A 55-year-old woman with a history of laparoscopic bilateral salpingo-oophorectomy and partial cystectomy for bladder endometriosis at the age of 44 years presented with worsening dysuria, decreased urine output, and malaise for over a week.

View Article and Find Full Text PDF

Ovarian carcinosarcoma in hereditary breast and ovarian cancer syndrome is rare. A 43-year-old woman with a family history of prostate and uterine or ovarian cancer had an 8-cm mass in the right ovary. Although computed tomography suggested peritoneal dissemination to the Douglas pouch, she wanted to preserve her fertility; therefore, she underwent a right salpingo-oophorectomy.

View Article and Find Full Text PDF
Article Synopsis
  • PARP inhibitors have improved outcomes for ovarian cancer patients, but the best approach for those who relapse during maintenance therapy is unclear.
  • A study examined the effects of platinum-based chemotherapy following PARP-i treatment in recurrent ovarian cancer patients, finding that the addition of bevacizumab significantly improved progression-free survival (PFS).
  • Among 66 patients evaluated, the median PFS for chemotherapy alone was 3.1 months compared to 8.9 months when combined with bevacizumab, suggesting that this combination therapy could be more beneficial for patients.
View Article and Find Full Text PDF
Article Synopsis
  • - Diagnostic laparoscopy is valuable in managing gynecological cancers but can sometimes reveal other types of cancer, like occult breast cancer (OBC), which has no visible breast tumor.
  • - A case is presented of a 64-year-old woman with back pain and an ovarian tumor that was thought to be cancerous based on imaging, leading to a laparoscopic surgery.
  • - During the procedure, a cystic tumor was found in the ovary, but the nodules were identified as breast cancer despite no apparent breast lesions, resulting in a diagnosis of OBC.
View Article and Find Full Text PDF
Article Synopsis
  • Hypersensitivity reactions (HSRs) to chemotherapy, particularly carboplatin, are significant adverse events that can affect cancer drug therapy, prompting a study on desensitization methods.
  • The study included 136 patients with gynecological cancers undergoing carboplatin desensitization therapy between 2016 and 2020, tracking their treatment responses and HSR symptoms.
  • Findings revealed a 75% success rate for desensitization, with common symptoms like erythema and itching, while no deaths occurred during the study, indicating the need for awareness of potential HSRs.
View Article and Find Full Text PDF

While cancer cure is the primary goal, fertility preservation is also a cornerstone of the underlying principle of treatment for ovarian germ cell tumors. Growing teratoma syndrome (GTS) presents with growth of mature teratomas during or after chemotherapy. We report a case of successful treatment of GTS in the anterior abdominal wall involving reconstruction.

View Article and Find Full Text PDF
Article Synopsis
  • Malignant struma ovarii (MSO) is a rare form of cancer derived from ovarian tissue that contains thyroid elements, making diagnosis difficult due to ambiguous imaging criteria.
  • A case study presented involved a 50-year-old woman with a pelvic tumor that had unusual imaging characteristics indicative of thyroid tissue, observed using MRI and CT scans.
  • Surgical intervention (total abdominal hysterectomy and bilateral salpingo-oophorectomy) confirmed the presence of MSO in the right ovary, highlighting the potential for specific imaging features to suggest this uncommon diagnosis.
View Article and Find Full Text PDF

Retroperitoneal liposarcoma is a rare tumor, and its dedifferentiated subtype and a larger diameter are associated with a poor prognosis. However, there are few reports of retroperitoneal liposarcomas, both with a dedifferentiated subtype and a diameter of >30 cm. We report a case of a giant retroperitoneal liposarcoma with a dedifferentiated subtype.

View Article and Find Full Text PDF

Desensitization protocols of platinum-based agents are recommended for patients with a history of hypersensitivity reaction (HSR). Herein, we report the first case of a successful desensitization therapy with nedaplatin after HSR to carboplatin and nedaplatin for platinum-sensitive recurrent ovarian cancer. A 53 year-old woman was diagnosed with stage IIIC serous carcinoma of the ovary and underwent primary debulking surgery followed by an adjuvant chemotherapy.

View Article and Find Full Text PDF

Progesterone is used to treat uterine endometrial cancer in young patients wishing to preserve their fertility as well as in advanced or recurrent patients, but its response rate is limited. The antitumor effect of progesterone is mediated by progesterone receptor (PR) binding. Hence, loss of progesterone's therapeutic effect, i.

View Article and Find Full Text PDF

Background: The goal of this study is to assess the oncologic outcomes of elderly patients who underwent hysterectomy for endometrial cancer across three variables: hysterectomy approach, lymph node resection, and adjuvant therapy.

Methods: Hospital records of patients aged ≥ 70 years who underwent hysterectomy for endometrial cancer were obtained from 19 institutions. Patients were categorized into three risk groups: low, intermediate, and high.

View Article and Find Full Text PDF

This study aimed to evaluate the efficacy and safety of computed tomography-magnetic resonance imaging (CT-MRI)-guided multi-catheter interstitial brachytherapy for patients with bulky (≥4 cm) and high-risk, stage IIB-IVB advanced cervical cancer. Eighteen patients who underwent concurrent chemoradiotherapy with multi-catheter interstitial brachytherapy between September 2014 and August 2020 were enrolled. The prescribed dose of external beam radiotherapy was 45-50.

View Article and Find Full Text PDF

Laparoscopic surgery has become the gold standard treatment for endometriosis. Surgical treatment of deep endometriosis with colorectal involvement is challenging. It requires complete surgical excision of lesions despite a high risk of complications that include rectal injury, rectovaginal fistula and pelvic abscess.

View Article and Find Full Text PDF

Estrogen-related receptor alpha (ERRα), which shares structural similarities with estrogen receptors, is associated with tumor progression in endometrial cancer, but little is known about the detailed underlying mechanism. We investigated whether ERRα, in cooperation with peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), could participate in epithelial-mesenchymal transition (EMT) in endometrial cancer through cancer-stromal interactions. Two endometrial cancer cell lines, Ishikawa and HEC-1A, transfected with ERRα/PGC-1α expression plasmids or silenced for ERRα expression, were co-cultured with telomerase-transformed human endometrial stromal cells (T-HESCs).

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on XCT790, a selective inverse agonist of the estrogen-related receptor (ERR) α, which is linked to uterine endometrial cancer progression.
  • Researchers found that XCT790 effectively inhibits transcriptional activity and cell proliferation in endometrial cancer cells, leading to increased apoptosis and cell cycle arrest.
  • In animal models, XCT790 demonstrated significant anti-tumor effects without affecting body weight, suggesting its potential as a new therapy for endometrial cancer.
View Article and Find Full Text PDF

Malignant hyperthermia (MH) is a life-threatening clinical syndrome of hypermetabolism involving skeletal muscle. Susceptibility to MH is inherited in an autosomal dominant manner. Its common trigger is exposure to volatile anesthetic agents or depolarizing muscle relaxants.

View Article and Find Full Text PDF

Estrogen-related receptor (ERR)α presents structural similarities with estrogen receptor (ER)α. However, it is an orphan receptor not binding to naturally occurring estrogens. This study was designed to investigate the role of ERRα in endometrial cancer progression.

View Article and Find Full Text PDF